Lantern Pharma (LTRN) Institutional Ownership $3.25 +0.12 (+3.83%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lantern Pharma (NASDAQ:LTRN)CurrentInstitutional OwnershipPercentage28.62%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$409.73KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$232.84K Get LTRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LTRN Institutional Buying and Selling by Quarter Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Lantern Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024Renaissance Technologies LLC81,800$382K0.0%+24.5%0.760% 8/9/2024Dimensional Fund Advisors LP18,413$86K0.0%+55.7%0.171% 8/2/2024CM Management LLC80,000$374K0.3%+23.1%0.743% 7/17/2024Westside Investment Management Inc.11,500$54K0.0%N/A0.107% 5/14/2024CM Management LLC65,000$572K0.5%-18.8%0.604% 5/10/2024Tocqueville Asset Management L.P.19,000$167K0.0%N/A0.177% Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 4/10/2024 Pathway Financial Advisors LLC25,001$220K0.1%-12.3%0.233% 2/12/2024Redmond Asset Management LLC40,662$174K0.1%-12.6%0.374% 2/8/2024Meridian Wealth Management LLC19,660$84K0.0%+18.0%0.181% 2/1/2024Sigma Planning Corp11,875$51K0.0%-34.5%0.109% 2/1/2024 Pathway Financial Advisors LLC28,501$122K0.0%-13.0%0.262% 10/30/2023 Pathway Financial Advisors LLC32,771$112K0.0%+134.1%0.302% 10/17/2023Meridian Wealth Management LLC16,660$57K0.0%N/A0.153% 8/10/2023Carlson Capital L P95,000$536K0.0%-23.9%0.875% 8/4/2023CM Management LLC75,000$423K0.4%+25.0%0.691% 7/19/2023 Pathway Financial Advisors LLC14,001$79K0.0%N/A0.129% 2/9/2023CM Management LLC60,000$362K0.4%+20.0%0.552% 2/9/2023 Wolff Wiese Magana LLC27,098$164K0.1%-11.0%0.250% 2/7/2023Lynwood Capital Management Inc.12,000$73K0.1%N/A0.110% 11/15/2022Carlson Capital L P168,000$803K0.1%-1.2%1.547% 11/4/2022CM Management LLC50,000$239K0.3%+10.9%0.462% 8/8/2022CM Management LLC45,100$258K0.3%+33.6%0.416% 7/15/2022 Wolff Wiese Magana LLC31,575$180K0.1%-12.7%0.292% 7/11/2022 Sanders Morris Harris LLC366,030$2.06M0.5%-4.7%3.379% 5/9/2022CM Management LLC33,765$241K0.2%N/A0.312% 5/9/2022 Wolff Wiese Magana LLC36,155$259K0.2%+5.9%0.334% 4/11/2022 Sanders Morris Harris LLC384,228$2.75M0.5%+14.2%3.564% 2/4/2022Envestnet Asset Management Inc.10,542$84K0.0%N/A0.094% 2/4/2022Redmond Asset Management LLC49,187$393K0.1%+3.7%0.440% 2/3/2022Advisor Group Holdings Inc.5,331$43K0.0%+92.5%0.048% 2/2/2022 Sanders Morris Harris LLC336,425$2.57M0.4%N/A3.007% 2/2/2022Sigma Planning Corp17,600$140K0.0%N/A0.157% 1/14/2022 Spire Wealth Management4,050$32K0.0%+285.7%0.036% 11/9/2021BlackRock Inc.23,074$258K0.0%-8.1%0.206% 11/5/2021Advisor Group Holdings Inc.2,770$31K0.0%+177.0%0.025% 11/2/2021Raymond James & Associates25,879$289K0.0%N/A0.231% 10/29/2021GWM Advisors LLC155,859$1.74M0.0%+3.0%1.394% 10/22/2021Redmond Asset Management LLC47,442$530K0.2%+4.3%0.424% 10/15/2021 Wolff Wiese Magana LLC35,316$395K0.3%+24.7%0.316% 8/16/2021Corriente Advisors LLC656,364$9.58M5.2%-8.0%5.869% Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now…8/13/2021Geode Capital Management LLC55,479$809K0.0%+21.1%0.496% 8/13/2021Vanguard Group Inc.269,429$3.93M0.0%+4.0%2.409% 8/11/2021Bank of New York Mellon Corp26,765$391K0.0%+127.3%0.239% 7/31/2021GWM Advisors LLC151,316$2.21M0.1%N/A1.353% 5/21/2021Citadel Advisors LLC11,192$203K0.0%N/A0.100% 5/18/2021Millennium Management LLC42,106$764K0.0%N/A0.377% 5/18/2021Morgan Stanley50,702$920K0.0%+81.6%0.453% 5/18/2021Corriente Advisors LLC713,806$12.95M4.8%N/A6.384% 5/18/2021Citadel Advisors LLC11,192$203K0.0%N/A0.100% 5/13/2021Bank of New York Mellon Corp11,775$213K0.0%N/A0.105% 5/12/2021Northern Trust Corp12,629$229K0.0%N/A0.113% 5/12/2021Geode Capital Management LLC45,830$831K0.0%N/A0.410% 5/12/2021UBS Group AG2,166$39K0.0%N/A0.019% 5/7/2021BlackRock Inc.23,650$429K0.0%+351.2%0.212% 5/6/2021Redmond Asset Management LLC44,991$816K0.3%N/A0.402% 5/3/2021 Flagship Harbor Advisors LLC147,671$2.68M0.3%N/A1.321% 4/28/2021 US Bancorp DE2,000$36K0.0%N/A0.018% 4/15/2021 Wolff Wiese Magana LLC27,075$491K0.4%N/A0.242% 2/5/2021CM Management LLC10,000$193K0.2%N/A0.095% 11/13/2020Morgan Stanley21,384$403K0.0%N/A0.344% 11/12/2020Voss Capital LLC35,067$661K0.4%N/A0.564% 11/9/2020Zeke Capital Advisors LLC84,750$1.60M0.2%-29.2%1.363% 11/6/2020BlackRock Inc.5,009$94K0.0%N/A0.081% (Data available from 1/1/2016 forward) LTRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LTRN shares? During the previous two years, 12 institutional investors and hedge funds held shares of Lantern Pharma. The most heavily invested institutionals were Carlson Capital L P ($536K), Renaissance Technologies LLC ($382K), CM Management LLC ($374K), Pathway Financial Advisors LLC ($220K), Redmond Asset Management LLC ($174K), Tocqueville Asset Management L.P. ($167K), and Wolff Wiese Magana LLC ($164K).Learn more on LTRN's institutional investors. What percentage of Lantern Pharma stock is owned by institutional investors? 28.62% of Lantern Pharma stock is owned by institutional investors. Learn more on LTRN's institutional investor holdings. Which institutional investors have been buying Lantern Pharma stock? The following institutional investors have purchased Lantern Pharma stock in the last 24 months: CM Management LLC ($44.90K), Pathway Financial Advisors LLC ($32.77K), Meridian Wealth Management LLC ($19.66K), Tocqueville Asset Management L.P. ($19K), Renaissance Technologies LLC ($16.10K), Lynwood Capital Management Inc. ($12K), and Westside Investment Management Inc. ($11.50K). How much institutional buying is happening at Lantern Pharma? Institutional investors have bought a total of 162,516 shares in the last 24 months. This purchase volume represents approximately $850.42K in transactions. Which Lantern Pharma major shareholders have been selling company stock? The following institutional investors have sold Lantern Pharma stock in the last 24 months: Carlson Capital L P ($31.90K), CM Management LLC ($15K), Pathway Financial Advisors LLC ($7.77K), Sigma Planning Corp ($6.25K), Redmond Asset Management LLC ($5.84K), and Wolff Wiese Magana LLC ($3.36K). How much institutional selling is happening at Lantern Pharma? Institutional investors have sold a total of 70,128 shares in the last 24 months. This volume of shares sold represents approximately $431.35K in transactions. Related Companies PRPH Major Shareholders BTAI Major Shareholders TNXP Major Shareholders GBIO Major Shareholders TNYA Major Shareholders RPTX Major Shareholders CGEN Major Shareholders NVCT Major Shareholders SKYE Major Shareholders TELO Major Shareholders This page (NASDAQ:LTRN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
